Thomas P. Steindler - McDermott Will & Emery


Thomas P. Steindler, head of the Intellectual Property Litigation Practice Group in Washington, DC, focuses his practice on intellectual property litigation along with complex commercial and administrative litigation. He has appeared in state and federal courts at all levels and has argued before the US Supreme Court. He is consistently recognized by Washington Super Lawyers as one of the leading intellectual property litigators in Washington, DC.

Show More


  • Acted for a major pharmaceutical company in a billion-dollar international arbitration in successful defense of a claim for royalties under licensing agreements with regard to the company’s biggest selling product.
  • Acted as lead counsel in securing a complete victory for Bausch Health in Hatch-Waxman litigation against Padagis LLC with regard to topical products for treatment of psoriasis.
  • Acted as lead counsel for a U.S. biotech company in successful arbitration of dispute with French licensee pertaining to license of AAV vectors for gene therapy products.
  • Acted as lead counsel for a global pharmaceutical company in a successful arbitration of a high-stakes licensing dispute involving HCV inhibitor technology.

Show More


  • LMG Life Sciences 2021-2022 – Leading Life Sciences Lawyer
  • LMG Life Sciences, Shortlisted for General Patent Litigator of the Year – DC Metro, 2021
  • Legal 500 US, 2021 and 2022
  • Managing Intellectual Property, IP Stars, 2020 & 2021
  • Intellectual Asset Management (IAM) Patent 1000 – The World’s Leading Patent Practitioners, 2017 to 2022


George Washington University Law School, JD, 1985
University of Oxford, MA, 1980
University of Illinois at Urbana-Champaign, BA, 1978

District of Columbia

Courts / Agencies
Supreme Court of the United States
US Court of Appeals for the Federal Circuit

Show More